Presentations from 34th Annual International Prostate Cancer Update
Welcome and Opening Remarks
E. David Crawford, MD, presented this lecture during the 34th Annual International Prostate Cancer Update on February 11, 2024, in Vail, Colorado.
Cardiovascular Side Effects
Robert H. Eckel, MD, FAHA, FACC, FNLA, presented this lecture during the 34th Annual International Prostate Cancer Update on February 11, 2024, in Vail, Colorado.
Bone Health and Non-cardiovascular Side Effects of ADT
Scott B. Sellinger, MD, presented this lecture during the 34th Annual International Prostate Cancer Update on February 11, 2024, in Vail, Colorado.
Implementing Changes in Patient Behavior
Jason M. Hafron, MD, presented this lecture during the 34th Annual International Prostate Cancer Update on February 11, 2024, in Vail, Colorado.
Session 1: Panel Discussion / Q&A
Scott B. Sellinger, MD, moderated this discussion during the 34th Annual International Prostate Cancer Update on February 11, 2024, in Vail, Colorado.
Industry Sponsored Educational program: Prostate 360
E. David Crawford, MD, presented this lecture during the 34th Annual International Prostate Cancer Update on February 11, 2024, in Vail, Colorado.
Welcome and Introductory Remarks
E. David Crawford, MD, presented this lecture during the 34th Annual International Prostate Cancer Update on February 12, 2024, in Vail, Colorado.
Molecular Targeted Imaging
Phillip J. Koo, MD, presented this lecture during the 34th Annual International Prostate Cancer Update on February 12, 2024, in Vail, Colorado.
Clinical Impact of PSMA PET Prior to Prostatectomy
Robert E. Reiter, MD, presented this lecture during the 34th Annual International Prostate Cancer Update on February 12, 2024, in Vail, Colorado.
Imaging and rhPSMA
Sean P. Collins, MD, PhD, presented this lecture during the 34th Annual International Prostate Cancer Update on February 12, 2024, in Vail, Colorado.
Challenging Case Discussion: Molecular Targeted Imaging
Robert E. Reiter, MD, presented this lecture during the 34th Annual International Prostate Cancer Update on February 12, 2024, in Vail, Colorado.
Session 2: Panel Discussion / Q&A
Phillip J. Koo, MD, moderated this lecture during the 34th Annual International Prostate Cancer Update on February 12, 2024, in Vail, Colorado.
2024 Legislative and Regulatory Updates
David M. Albala, MD, and Mara R. Holton, MD, presented this lecture during the 34th Annual International Prostate Cancer Update on February 12, 2024, in Vail, Colorado.
Panel Discussion – Session 3
Scott B. Sellinger, MD, moderated this lecture during the 34th Annual International Prostate Cancer Update on February 12, 2024, in Vail, Colorado.
Putting Germline Testing into Context: A Primer and Current Knowledge
Alan H. Bryce, MD, presented this lecture during the 34th Annual International Prostate Cancer Update on February 12, 2024, in Vail, Colorado.
Pros and Cons of the REIMAGINE Trial
Matthew R. Cooperberg, MD, MPH, presented this lecture during the 34th Annual International Prostate Cancer Update on February 12, 2024, in Vail, Colorado.
Debate: The Role of Germline Genetics in Prostate Cancer Screening (Pro)
Brian T. Helfand, MD, PhD, presented this lecture during the 34th Annual International Prostate Cancer Update on February 12, 2024, in Vail, Colorado.
Debate: The Role of Germline Genetics in Prostate Cancer Screening (Con)
Sigrid V. Carlsson, MD, PhD, MPH, presented this lecture during the 34th Annual International Prostate Cancer Update on February 12, 2024, in Vail, Colorado.
The Future of AI in Pathologic Evaluation of Prostate Cancer
Francisco G. LaRosa, MD, FCAP, presented this lecture during the 34th Annual International Prostate Cancer Update on February 12, 2024, in Vail, Colorado.
Panel Discussion: Guidelines and Treatment for Early Detection
Matthew R. Cooperberg, MD, MPH, presented this lecture during the 34th Annual International Prostate Cancer Update on February 12, 2024, in Vail, Colorado.
Alan Partin Lecture: The Genomics and Natural History of Visible vs. Invisible Cancers
Laurence Klotz, MD, FRCSC, presented this lecture during the 34th Annual International Prostate Cancer Update on February 12, 2024, in Vail, Colorado.
High Resolution Micro-ultrasound vs. MRI for Staging and Diagnosis
Laurence Klotz, MD, FRCSC, presented this lecture during the 34th Annual International Prostate Cancer Update on February 13, 2024, in Vail, Colorado.
Brian Moran Distinguished Lecture: Mobilizing Moran’s Army from Seed to Shining Seed
Peter F. Orio III, DO, MS, presented this lecture during the 34th Annual International Prostate Cancer Update on February 13, 2024, in Vail, Colorado.
Ablative Local Technologies (HIFU, Cryo, SBRT, Laser, and other Forms of Energy)
David M. Albala, MD, presented this lecture during the 34th Annual International Prostate Cancer Update on February 13, 2024, in Vail, Colorado.
Panel Discussion: Choosing the Right Modality for Your Patient
A. Karim Kader, MD, PhD, FRCSC, and Laurence Klotz, MD, FRCSC, presented this lecture during the 34th Annual International Prostate Cancer Update on February 13, 2024, in Vail, Colorado.
Treatment of Oligometastatic Prostate Cancer in the Era of PSMA PET Imaging
Andrew W. Hahn, MD, presented this lecture during the 34th Annual International Prostate Cancer Update on February 13, in Vail, Colorado.
High-risk Localized and Oligometastatic Disease
Christopher J. Kane, MD, presented this lecture during the 34th Annual International Prostate Cancer Update on February 13, 2024, in Vail, Colorado.
Rationale for Involved Site SBRT-Enhanced Intermittent Androgen Deprivation Therapy in Nodal Oligorecurrent Prostate Cancer
Sean P. Collins, MD, PhD, presented this lecture during the 34th Annual International Prostate Cancer Update on February 13, 2024, in Vail, Colorado.
Role of Molecular Targeted Imaging in Oligometastatic Disease
Phillip J. Koo, MD, presented this lecture during the 34th Annual International Prostate Cancer Update on February 13, 2024, in Vail, Colorado.
Choosing Systemic Therapy for Men with Metastatic Hormone Sensitive Prostate Cancer
Andrew W. Hahn, MD, presented this lecture during the 34th Annual International Prostate Cancer Update on February 13, 2024, in Vail, Colorado.
Doublets and Triplets: Patient Selection
David S. Morris, MD, FACS, presented this lecture during the 34th Annual International Prostate Cancer Update on February 13, 2024, in Vail, Colorado.
APC Pathways – The Large Urology Group Practice Model
Jeffrey M. Spier, MD, presented this lecture during the 34th Annual International Prostate Cancer Update on February 13, 2024, in Vail, Colorado.
Financial Toxicity of APC Management
R. Jonathan Henderson, MD, presented this lecture during the 34th Annual International Prostate Cancer Update on February 13, 2024, in Vail, Colorado.
Challenging Case Discussion
Alan H. Bryce, MD, moderated this lecture during the 34th Annual International Prostate Cancer Update on February 13, 2024, in Vail, Colorado.
The Microbiome and Prostate Cancer
Michael A. Liss, MD, PhD, MAS, FACS, presented this lecture during the 34th Annual International Prostate Cancer Update on February 13, 2024, in Vail, Colorado.
Therapeutic Modalities for BPH
Brian T. Helfand, MD, PhD, presented this lecture during the 34th Annual International Prostate Cancer Update on February 13, 2024, in Vail, Colorado.
Pathological Aspects of BPH, Prostatitis, and Other Painful Co-occurrences
Francisco G. LaRosa, MD, FCAP, presented this lecture during the 34th Annual International Prostate Cancer Update on February 13, 2024, in Vail, Colorado.
Optilume for BPH – Considerations for Use
Ryan P. Terlecki, MD, FACS, presented this lecture during the 34th Annual International Prostate Cancer Update on February 13, 2024, in Vail, Colorado.
Session 8: BPH, Prostatitis, and Other Co-occurrences – Panel Discussion – Q&A
Brian T. Helfand, MD, PhD, moderated this lecture during the 34th Annual International Prostate Cancer Update on February 13, 2024, in Vail, Colorado.
Perspectives in mCRPC in 2024
Alan H. Bryce, MD, presented this lecture during the 34th Annual International Prostate Cancer Update on February 14, 2024, in Vail, Colorado.
Assessing and Managing Metabolic Risk in Patients with Prostate Cancer
Robert H. Eckel, MD, FAHA, FACC, FNLA, presented this lecture during the 34th Annual International Prostate Cancer Update on February 14, 2024, in Vail, Colorado.
PARPi in mCRPC
Daniel P. Petrylak, MD, presented this lecture during the 34th Annual International Prostate Cancer Update on February 14, 2024, in Vail, Colorado.
Integrating Care in APC
John W. Davis, MD, presented this lecture during the 34th Annual International Prostate Cancer Update on February 14, 2024, in Vail, Colorado.
Panel Discussion / Q&A
Andrew W. Hahn, MD, moderated this lecture during the 34th Annual International Prostate Cancer Update on February 14, 2024, in Vail, Colorado.
Mortality and Prostate Cancer: Updates from Mexico
Arturo Mendoza-Valdes, MD, presented this lecture during the 34th Annual International Prostate Cancer Update on February 14, 2024, in Vail, Colorado.
Updates from India
Kshitij Pandit, MD, presented this lecture during the 34th Annual International Prostate Cancer Update on February 14, 2024, in Vail, Colorado.
Prostate Cancer in Canada
Laurence Klotz, MD, FRCSC, presented this lecture during the 34th Annual International Prostate Cancer Update on February 14, 2024, in Vail, Colorado.
Updates from China
Peter K.F. Chiu, MD, PhD, FRCSEd, presented this lecture during the 34th Annual International Prostate Cancer Update on February 14, 2024, in Vail, Colorado.
MRI-invisible Prostate Cancer and Use of Biomarkers to Identify Potential Candidates
Priya N. Werahera, PhD, presented this lecture during the 34th Annual International Prostate Cancer Update on February 14, 2024, in Vail, Colorado.
Artificial Intelligence and Extended Reality for Urology Training
Nelson N. Stone, MD, presented this lecture during the 34th Annual International Prostate Cancer Update on February 14, 2024, in Vail, Colorado.
AI in Healthcare: The Hype, The Reality and the Promise
A. Karim Kader, MD, PhD, FRCSC, presented this lecture during the 34th Annual International Prostate Cancer Update on February 14, 2024, in Vail, Colorado.
How to Use Natural Ligands to Kill Tumor Stem Cells
Stephen B. Howell, MD, presented this lecture during the 34th Annual International Prostate Cancer Update on February 14, 2024, in Vail, Colorado.
Closing Remarks
E. David Crawford, MD, presented this lecture during the 34th Annual International Prostate Cancer Update on February 14, 2024, in Vail, Colorado.